Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.59% is 48% below its 5-year average of 1.13%, near the low end of its 5-year range (0.59%–1.80%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.14% below its 12-month average of 0.71%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.59%.
DEBT TO ASSETS RATIO
0.59%
DEBT TO ASSETS RATIO AVG TTM
0.71%
DEBT TO ASSETS RATIO AVG 3Y
0.84%
DEBT TO ASSETS RATIO AVG 5Y
1.13%
DEBT TO ASSETS RATIO AVG 10Y
0.94%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-17.14%
CURRENT VS 3Y AVG
-30.03%
CURRENT VS 5Y AVG
-47.63%
CURRENT VS 10Y AVG
-37.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
+489.95%
vs the sector median at left
Krystal Biotech, Inc.
Market Cap
$9.74B
Debt to Assets Ratio
0.59%
TTM Avg
0.71%
3Y Avg
0.84%
5Y Avg
1.13%
Market Cap
$10.02B
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.10B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.11B
Debt to Assets Ratio
0.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.19B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | $9.74B | 0.59% | 0.71% | 0.84% | 1.13% |
| Henry Schein, Inc. (HSIC)vs › | $9.75B | 0.34% | N/A | N/A | N/A |
| Vaxcyte, Inc. (PCVX)vs › | $9.59B | 0.04% | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.02B | 0.12% | N/A | N/A | N/A |
| Molina Healthcare, Inc. (MOH)vs › | $10.10B | 0.25% | N/A | N/A | N/A |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 0.39% | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $9.36B | 0.30% | N/A | N/A | N/A |
| Bruker Corporation (BRKR)vs › | $9.31B | 0.32% | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.19B | 0.02% | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.30B | 0.02% | N/A | N/A | N/A |
Debt/Assets
0.6%
Debt/Equity
0.01
Current Ratio
8.32
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.59% |
| 2026-03-31 | 0.65% |
| 2025-12-31 | 0.70% |
| 2025-09-30 | 0.77% |
| 2025-06-30 | 0.85% |
| 2025-03-31 | 0.90% |
| 2024-12-31 | 0.69% |
| 2024-09-30 | 0.76% |
| 2024-06-30 | 0.84% |
| 2024-03-31 | 0.93% |
| 2023-12-31 | 0.99% |
| 2023-09-30 | 1.05% |
| 2023-06-30 | 1.25% |
| 2023-03-31 | 1.65% |
| 2022-12-31 | 1.60% |
| 2022-09-30 | 1.58% |
| 2022-06-30 | 1.52% |
| 2022-03-31 | 1.51% |
| 2021-12-31 | 1.28% |
| 2021-09-30 | 1.80% |
| 2021-06-30 | 1.77% |
| 2021-03-31 | 0.87% |
| 2020-12-31 | 3.71% |
| 2020-09-30 | 0.99% |
| 2020-06-30 | 0.99% |
| 2020-03-31 | 1.56% |
| 2019-12-31 | 1.56% |
| 2019-09-30 | 1.55% |
| 2019-06-30 | 1.64% |
| 2019-03-31 | 2.93% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 99.63% |
| 2016-12-31 | 84.46% |
